Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALE $2.29 0.2100 +10.10%
EPZM $23.35 1.6900 +7.80%
SPPI $7.18 0.2800 +4.06%
BDSI $8.66 0.1900 +2.24%
NYMX $5.24 0.0900 +1.75%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.21 -0.1099 -34.34%
IMNP $3.96 -0.5300 -11.80%
TGTX $5.16 -0.6600 -11.34%
IMMU $4.15 -0.4200 -9.19%
GERN $2.00 -0.1900 -8.68%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

FDA Approves GSK's Tanzeum to Treat Type 2 Diabetes

(Reuters) Apr 15, 2014 - The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's Tanzeum injection for treating adults with type 2 diabetes, in combination with diet and exercise.
read article 

More U.S. Consumers Are Seeking Medical Care, Report Shows

(Los Angeles Times) Apr 15, 2014 - Suggesting a lengthy slowdown in healthcare spending could be over, Americans show higher demand for specialists, and other services.
read article (free registration required) 

Prices Soaring for Specialty Drugs, Researchers Find

(New York Times) Apr 15, 2014 - A report to be released on Tuesday by a major drug research firm says that even as prescription costs have plummeted, a small slice of the population with serious illnesses is being asked to shoulder more of the cost of expensive treatments.
read article 

Essay: A Radiation Reality Check

(Wall Street Journal) Apr 11, 2014 - From bananas to bricks, radioactivity is everywhere—but it's nothing to be afraid of.
read article (paid subscription required) 

MolecularHealth Launches Blog on the News, Trends and Technologies Shaping the Targeted Treatment of Cancer

(Yahoo! Finance) Apr 15, 2014 - The Targeting Cancer blog keeps oncologists, pathologists, patients and payers up-to-date on new developments in cancer treatment that promise a revolution in cancer care
read article 

Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. as Head of R&D and Chief Medical Officer

(Tokai Pharmaceuticals) Apr 15, 2014 - Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven diseases, today announced the appointment of Karen J. Ferrante, M.D. as head of R&D and chief medical officer.
read corporate press release 

Ohio State Hematologist Recognized Nationally With Top 10 Clinical Research Achievement Award

(OSUCCC - James) Apr 9, 2014 - John C. Byrd, MD, has again received national scientific recognition for his translational research investigating use of the drug, ibrutinib, in the treatment of chronic lymphocytic leukemia (CLL), at the 2014 Clinical Research Forum’s third annual Top 10 Research Achievement Awards.
read press release 

Pope Foundation Gives $1.3M to Cancer Research at UNC-Chapel Hill

(The News & Observer [Raleigh, NC]) Apr 14, 2014 - The John William Pope Foundation has made a $1.3 million gift to UNC-Chapel Hill for cancer research and treatment.
read article 

Cardio-Oncology Clinic Established at The Mount Sinai Hospital

(Mount Sinai Hospital) Apr 15, 2014 - Cardiologists and cancer experts at The Mount Sinai Hospital have joined forces to establish its first Cardio-Oncology Clinic at The Tisch Cancer Institute at The Mount Sinai Hospital.
read press release 

Cancer Center Agrees to $2.9M Settlement in Whistleblower Case

(Kansas City Business Journal) Apr 14, 2014 - Hope Cancer Institute Inc. and owner Dr. Raj Sadasivan have agreed to pay $2.9 million to the U.S. government to settle claims that the organization defrauded federal health care programs.
read article 

High-risk PCa: Urological or Radiation Oncological Approach

(EAU) Apr 15, 2014 - In the multidisciplinary Thematic Session 18, the urological and radiation oncological approaches to high-risk prostate cancer were discussed.
read article 

Plenary Session 5: Update and Controversies in Prostate Cancer

(EAU) Apr 15, 2014 - The last Plenary Session of this year’s event dealt with all aspects of prostate cancer, from genomic alterations to risk stratification.
read article 

Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava™ Blood Tests For Breast Cancer Detection

( Apr 15, 2014 - Eventus Diagnostics, Inc. announced completion of a $2.72 million financing, the proceeds of which will mostly be used to support the continued development and commercialization of the company's Octava™ breast cancer tests.
read article 

Roche’s Breast-Cancer Drug Sales Surge, Led by Perjeta

(Bloomberg) Apr 15, 2014 - Roche Holding AG’s sales of breast-cancer medicines grew 17 percent in the first quarter as new drugs beat analysts’ estimates, eclipsing a decline in overall revenue.
read article 

AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) for Patients with Non-Small Cell Lung Cancer

(Yahoo! Finance) Apr 15, 2014 - Trial will evaluate investigational compound's efficacy and safety as an addition to standard chemotherapy in previously-untreated patients.
read article 

3D-printed Kidneys Could Become Standard for Simulated Cancer Surgery

(Medical News Today) Apr 14, 2014 - At the European Association of Urology congress in Stockholm, Sweden, surgeons from Japan announced that they have created 3D-printed tumor-containing kidneys for the use of simulated cancer surgery.
read article 

MicroRNA Could be Key Target for Bowel Cancer Treatment

(ICR [UK]) Apr 14, 2014 - A tiny genetic molecule known as a microRNA plays a central role in bowel cancer and could be key to developing new treatments for the disease, a new study concludes.
read press release 

Fiber's Cancer-fighting Effect Depends on Gut Bacteria

(Fox News/LiveScience) Apr 14, 2014 - A high-fiber diet may protect against colon cancer, but only if you have the right gut bacteria, a new study in mice suggests.
read article 

Unexpected Protein Partnership Has Implications for Cancer Treatment

(NIH) Apr 15, 2014 - Scientists have identified two unlikely partners in a type of immune cell called a macrophage that work together in response to cancer drugs to increase inflammation in a way that may alter tumor growth.
read press release 

Three-gene Test May Aid Earlier Lung Cancer Detection

( Apr 14, 2014 - Methylation of three genes may help with the early diagnosis of non-small-cell lung cancer (NSCLC), research suggests.
read article 

Longest Prostate Cancer Active Surveillance Study Promising

(Medscape Medical News) Apr 14, 2014 - The longest follow-up to date of active surveillance in patients with favorable or intermediate-risk prostate cancer shows that it is a safe and feasible approach for as long as 20 years after diagnosis.
read article (free registration required) 

Positive Results From Enzalutamide Study on Metastatic Prostate Cancer Patients

(EAU) Apr 15, 2014 - The results of the Phase 3 Prevail Study on enzalutamide showed significant benefit to prostate cancer patients, including delaying the progression of metastatic disease, reducing the risk of death, and delaying the start of cytotoxic chemotherapy.
read article 

New Blood Test May Detect Breast Cancer Spread

(Baltimore Sun) Apr 15, 2014 - Johns Hopkins cancer researchers and collaborators around the country have developed a blood test that they believe can tell when breast cancer has spread and can accurately monitor the cancer’s response to treatment.
read article 

Gene Panel Effectively Screens Dozens of Genes for Cancer-associated Mutations, Study Finds

(Stanford School of Medicine) Apr 14, 2014 - As many as 10 percent of women with a personal or family history of breast or ovarian cancer have at least one genetic mutation that, if known, would prompt their doctors to recommend changes in their care, according to a new study.
read article 

New Guidelines Address Cancer Survivors' Issues

(MedPage Today) Apr 14, 2014 - Acknowledging successes in the war on cancer, three new clinical guidelines address problems frequently encountered by cancer survivors: fatigue, peripheral neuropathy, and anxiety and depression.
read article (free registration required)